Your browser doesn't support javascript.
loading
Rates of and Factors Associated With Placebo Response in Trials of Pharmacotherapies for Nonalcoholic Steatohepatitis: Systematic Review and Meta-analysis.
Han, Ma Ai Thanda; Altayar, Osama; Hamdeh, Shadi; Takyar, Varun; Rotman, Yaron; Etzion, Ohad; Lefebvre, Eric; Safadi, Rifaat; Ratziu, Vlad; Prokop, Larry J; Murad, Mohammad Hassan; Noureddin, Mazen.
Affiliation
  • Han MAT; Division of Digestive and Liver Diseases, Cedars-Sinai Medical Center, Los Angeles, California.
  • Altayar O; Division of Gastroenterology, Washington University School of Medicine, St. Louis, Missouri.
  • Hamdeh S; Division of Gastroenterology, Hepatology and Motility, University of Kansas Medical Center, Kansas City, Kansas.
  • Takyar V; Liver & Energy Metabolism Unit, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Health, Bethesda, Maryland.
  • Rotman Y; Liver & Energy Metabolism Unit, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Health, Bethesda, Maryland.
  • Etzion O; Liver & Energy Metabolism Unit, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Health, Bethesda, Maryland.
  • Lefebvre E; Allergan, PLC, South San Francisco, California.
  • Safadi R; Liver and Gastroenterology Unit, Division of Medicine, Hadassah University Medical Center, Jerusalem, Israel.
  • Ratziu V; Institute for Cardiometabolism and Nutrition, Université Pierre et Marie Curie, Paris, France.
  • Prokop LJ; Mayo Clinic Libraries, Mayo Clinic, Rochester, Minnesota.
  • Murad MH; Evidence-based Practice Center, Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota.
  • Noureddin M; Fatty Liver Program, Division of Digestive and Liver Diseases, Comprehensive Transplant Program, Cedars-Sinai Medical Center, Los Angeles, California. Electronic address: mazen.noureddin@cshs.org.
Clin Gastroenterol Hepatol ; 17(4): 616-629.e26, 2019 03.
Article in En | MEDLINE | ID: mdl-29913275

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Placebos / Placebo Effect / Randomized Controlled Trials as Topic / Non-alcoholic Fatty Liver Disease Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Humans Country/Region as subject: America do sul Language: En Journal: Clin Gastroenterol Hepatol Year: 2019 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Placebos / Placebo Effect / Randomized Controlled Trials as Topic / Non-alcoholic Fatty Liver Disease Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Humans Country/Region as subject: America do sul Language: En Journal: Clin Gastroenterol Hepatol Year: 2019 Document type: Article